These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Muller WJ; Sinn E; Pattengale PK; Wallace R; Leder P Cell; 1988 Jul; 54(1):105-15. PubMed ID: 2898299 [TBL] [Abstract][Full Text] [Related]
3. Synergistic interaction of the Neu proto-oncogene product and transforming growth factor alpha in the mammary epithelium of transgenic mice. Muller WJ; Arteaga CL; Muthuswamy SK; Siegel PM; Webster MA; Cardiff RD; Meise KS; Li F; Halter SA; Coffey RJ Mol Cell Biol; 1996 Oct; 16(10):5726-36. PubMed ID: 8816486 [TBL] [Abstract][Full Text] [Related]
4. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Guy CT; Webster MA; Schaller M; Parsons TJ; Cardiff RD; Muller WJ Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10578-82. PubMed ID: 1359541 [TBL] [Abstract][Full Text] [Related]
5. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis. Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418 [TBL] [Abstract][Full Text] [Related]
6. Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene. Bouchard L; Lamarre L; Tremblay PJ; Jolicoeur P Cell; 1989 Jun; 57(6):931-6. PubMed ID: 2567634 [TBL] [Abstract][Full Text] [Related]
7. Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors. Landis MD; Seachrist DD; Abdul-Karim FW; Keri RA Oncogene; 2006 Jun; 25(23):3325-34. PubMed ID: 16434967 [TBL] [Abstract][Full Text] [Related]
8. Over-expression of erbB-2/neu is paralleled by inhibition of mouse-mammary-epithelial-cell differentiation and developmental apoptosis. Lazar H; Baltzer A; Gimmi C; Marti A; Jaggi R Int J Cancer; 2000 Feb; 85(4):578-83. PubMed ID: 10699933 [TBL] [Abstract][Full Text] [Related]
9. Preneoplastic mammary tumor markers: Cripto and Amphiregulin are overexpressed in hyperplastic stages of tumor progression in transgenic mice. Niemeyer CC; Spencer-Dene B; Wu JX; Adamson ED Int J Cancer; 1999 May; 81(4):588-91. PubMed ID: 10225449 [TBL] [Abstract][Full Text] [Related]
10. MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice. Zhou H; Chen WD; Qin X; Lee K; Liu L; Markowitz SD; Gerson SL Oncogene; 2001 Sep; 20(42):6009-17. PubMed ID: 11593408 [TBL] [Abstract][Full Text] [Related]
12. Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis. Moody SE; Sarkisian CJ; Hahn KT; Gunther EJ; Pickup S; Dugan KD; Innocent N; Cardiff RD; Schnall MD; Chodosh LA Cancer Cell; 2002 Dec; 2(6):451-61. PubMed ID: 12498714 [TBL] [Abstract][Full Text] [Related]
13. Induction of epithelial abnormalities that resemble human breast lesions by the expression of the neu/erbB-2 oncogene in reconstituted mouse mammary gland. Bradbury JM; Arno J; Edwards PA Oncogene; 1993 Jun; 8(6):1551-8. PubMed ID: 8099220 [TBL] [Abstract][Full Text] [Related]
14. Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors. Siegel PM; Dankort DL; Hardy WR; Muller WJ Mol Cell Biol; 1994 Nov; 14(11):7068-77. PubMed ID: 7935422 [TBL] [Abstract][Full Text] [Related]
15. Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion. Hutchinson JN; Jin J; Cardiff RD; Woodgett JR; Muller WJ Cancer Res; 2004 May; 64(9):3171-8. PubMed ID: 15126356 [TBL] [Abstract][Full Text] [Related]
17. Local delivery of recombinant vaccinia virus encoding for neu counteracts growth of mammary tumors more efficiently than systemic delivery in neu transgenic mice. Masuelli L; Marzocchella L; Focaccetti C; Lista F; Nardi A; Scardino A; Mattei M; Turriziani M; Modesti M; Forni G; Schlom J; Modesti A; Bei R Cancer Immunol Immunother; 2010 Aug; 59(8):1247-58. PubMed ID: 20364378 [TBL] [Abstract][Full Text] [Related]
18. Activation of Src family kinases in Neu-induced mammary tumors correlates with their association with distinct sets of tyrosine phosphorylated proteins in vivo. Muthuswamy SK; Muller WJ Oncogene; 1995 Nov; 11(9):1801-10. PubMed ID: 7478608 [TBL] [Abstract][Full Text] [Related]
19. A mouse model for breast cancer induced by amplification and overexpression of the neu promoter and transgene. Weinstein EJ; Kitsberg DI; Leder P Mol Med; 2000 Jan; 6(1):4-16. PubMed ID: 10803404 [TBL] [Abstract][Full Text] [Related]
20. In vivo evidence supporting a metastasis suppressor role for Stard13 (Dlc2) in ErbB2 (Neu) oncogene induced mouse mammary tumors. Basak P; Leslie H; Dillon RL; Muller WJ; Raouf A; Mowat MRA Genes Chromosomes Cancer; 2018 Apr; 57(4):182-191. PubMed ID: 29218825 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]